The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive and epidemiological characterization of urachal adenocarcinoma: A pan-Canadian collaboration.
 
Belkaid Wiam
No Relationships to Disclose
 
Zineb Hamilou
No Relationships to Disclose
 
Denis Soulieres
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Ipsen; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Christina M. Canil
Honoraria - Janssen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Roche
Research Funding - Eisai
Travel, Accommodations, Expenses - Amgen; Pfizer; Sanofi
 
Pawel Zalewski
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Pfizer
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst)
 
Vitor Da Silva
Speakers' Bureau - Astellas Oncology; Pfizer
 
Mathias Castonguay
No Relationships to Disclose
 
Bertrand Routy
No Relationships to Disclose
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Pfizer; Roche Canada; Sanofi
Research Funding - Merck